The effects of alginate encapsulation on NIT-1 insulinoma cells: Viability, growth and insulin secretion

In Vivo

Volumn 23, Issue 6, 2009, Pages 929-935

  Bertolotti, Alessia ^a,b   Borgogna, Massimiliano ^c   Facoetti, Angelica ^a,b   Marsich, Eleonora ^c   Nano, Rosanna ^a,b  

^a UNIVERSITY OF PAVIA   (Italy)

^b INFN SEZIONE DI PAVIA   (Italy)

^c UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Alginate; Cell viability; Encapsulation; Insulin secretion; NIT 1 cell

Indexed keywords

ALGINIC ACID; TRYPAN BLUE;

ANIMAL CELL; ARTICLE; CELL ENCAPSULATION; CELL GROWTH; CELL VIABILITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; INSULINOMA; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION;

EID: 75149161572     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Kim SC, Kim TH, We YM, Park HY, Cho KM and Han DJ: Study for improvement of early implantation and long-term graft survival in pancreatic islet cell transplantation by induction of angiogenesis with gene transfection of vascular endothelial growth factor. Transplant Proc 35: 486-487, 2003.
2. Kobayashi T, Aomatsu Y, Iwata H, Kin T, Kanehiro H, Hisanaga M, Ko S, Nagao M and Nakajima Y: Indefinite islet protection from autoimmune destruction in nonobese diabetic mice by agarose microencapsulation without immunosuppression. Transplantation 75: 619-625, 2003.
3. Garfinkel MR, Harland RC and Opara EC: Optimization of the microencapsulated islet for transplantation. J Surg Res 76: 7-10, 1998.
4. Benson JP, Papas KK, Constantinidis I and Sambanis A: Towards the development of a bioartificial pancreas: effects of poly-L-lysine on alginate beads with βTC3 cells. Cell Transplant 6: 395-402, 1997.
5. Desai TA, Chu WH, Rasi G, Sinibaldi-Vallebona P, Guarino E and Ferrari M: Microfabricated biocapsules provide short-term immunoisolation of insulinoma xenografts. Biomed Microdevices 1: 131-138, 1999.
6. Soon Shiong P: Treatment of type I diabetes using encapsulated islets. Adv Drug Deliv Rev 35: 259-270, 1999.
7. Duvivier-Kali VF, Omer A, Parent RJ, O'Neil JJ and Weir GC: Complete protection of islets against allorejection and autoimmunity by a simple barium-alginate membrane. Diabetes 50: 1698-1705, 2001.
8. Lim F and Sun AM: Microencapsulated islets as bioartificial endocrine pancreas. Science 210: 908-910, 1980.
9. Smidsrod O and Skjak-Braek G: Alginate as immobilization matrix for cells. Trends Biotechnol 8: 71-78, 1990.
10. Lanza RP, Jackson R, Sullivan A, Ringeling J, McGrath C, Kuhtreiber W and Chick WL: Xenotransplantation of cells using biodegradable microcapsules. Transplantation 67: 1105-1111, 1999.
11. De Vos P, Faas MM, Strand B and Calafiore R: Alginate-based microcapsules for immunoisolation of pancreatic islets. Biomaterials 27: 5603-5617, 2006.
12. Gorin PAJ and Spencer JFT: Exocellular alginic acid from Azotobacter vinelandii. Can J Chem 44: 993, 1966.
13. Govan JRW, Fyfe JAM and Jarman TR: Isolation of alginate-producing mutants of Pseudomonas fluorescens, Pseudomonas putida and Pseudomonas mendonica. J Gen Microbiol 125: 217, 1981.
14. Painter TJ: Algal polysaccharides. In: The Polysaccharides. Aspinall GO (ed.). New York, Academic Press, p. 195, 1983.
15. Haug A, Larsen B and Smidsrod O: A study of the constitution of alginic acid by partial hydrolysis. Acta Chem Scand 20: 183-190, 1966.
16. Klock G, Frank H, Houben R, Zekorn T, Horcher A, Siebers U, Wöhrle M, Federlin K and Zimmermann U: Production of purified alginates suitable for use in immunoisolated transplantation. Appl Microbiol Biotechnol 40: 638-643, 1994.
17. De Vos P, De Haan B and Van Schilfgaarde R: Effect of the alginate composition on the biocompatibility of alginate-polylysine microcapsules. Biomaterials 18: 273-278, 1997.
18. Klock G, Pfeffermann A, Ryser C, Gröhn P, Kuttler B, Hahn HJ and Zimmermann U: Biocompatibility of mannuronic acid-rich alginates. Biomaterials 18: 707-713, 1997.
19. Espevik T, Otterlei M, Skjak-Braek G, Ryan L, Wright SD and Sundan A: The involvement of CD14 in stimulation of cytokine production by uronic acid polymers. Eur J Immunol 23: 255-261, 1993.
20. Skjåk-Bræk G, Murano E and Paoletti S: Alginate as an immobilization material. II: Determination of polyphenol contaminants by fluorescence spectroscopy, and evaluation of methods for their removal. Biotechnol Bioeng 33: 90-94, 1989.
21. Mallett AG and Korbutt GS: Alginate modification improves long-term survival and function of transplanted encapsulated islets. Tissue Eng Part A 15: 1301-1309, 2008.
22. Hohmeier HE and Newgard CB: Cell lines derived from pancreatic islets. Mol Cell Endocrinol 228: 121-128, 2004.
23. Hayashi H, Inoue K, Aung T, Tun T, Yuanjun G, Wenjing W, Shinohara S, Kaji H, Doi R, Setoyama H, Kato M, Imamura M, Maetani S, Morikawa N, Iwata H, Ikada Y and Miyazaki J: Application of a novel B cell line MIN6 to a mesh-reinforced polyvinyl alcohol hydrogel tube and three-layer agarose microcapsules: an in vitro study. Cell Transplant 5: 65-69, 1996.
24. Ohgawara H, Miyazaki J, Nakagawa Y, Sato S, Karibe S and Akaike T: Xehoimplantation using a diffusion chamber with a B-cell line (MIN6) as a bioartificial endocrine pancreas (Bio-AEP). Cell Transplant 5: 71-73, 1996.
25. Strand BL, Gåserød O, Kulseng B, Espevik T and Skjåk-Bræk G: Alginate-polylysine-alginate microcapsules: effect of size reduction on capsule properties. J Microencapsul 19: 615-630, 2002.
26. Lum ZP, Tai IT, Krestow M, Norton J, Vacek I and Sun AM: Prolonged reversal of diabetic state in NOD mice by xenografts of microencapsulated rat islets. Diabetes 40: 1511-1516, 1991.
27. Soon-Shiong P, Heintz RE, Merideth N, Yao QX, Yao Z, Zheng T, Murphy M, Moloney MK, Schmehl M, Harris M, Mendez R and Sanford PA: Insulin independence in a type 1 diabetic patient after encapsulated islet transplantation. Lancet 343: 950-951, 1994.
28. Bratanova-Tochkova TK, Cheng H, Daniel S, Gunawardana S, Liu YJ, Mulvaney-Musa J, Schermerhorn T, Straub SG, Yajima H and Sharp GW: Triggering and augmentation mechanisms, granule pools, and biphasic insulin secretion. Diabetes 51: 83-90, 2002.
29. Henquin JC, Ishiyama N, Nenquin M, Ravier MA and Jonas JC: Signals and pools underlying biphasic insulin secretion. Diabetes 51: 60-67, 2002.
30. Straub SG and Sharp GWG: Glucose-stimulated signalling pathways in biphasic insulin secretion. Diabetes Metab Res Rev 18: 451-463, 2002.
31. Cheng SY, Constantinidis I and Sambanis A: Insulin secretion dynamics of free and alginate-encapsulated insulinoma cells. Cytotechnology 51: 159-170, 2006.
32. Jimenez-Feltstrom J, Lundquist I, Obermuller S and Salehi A. Insulin feedback action: complex effects involving isoforms of islet nitric oxide synthase. Regul Pept 122: 109-118, 2004.
33. Luciani DS and Johnson DJ: Acute effects of insulin on beta-cells from transplantable human islets. Mol Cell Endocrinol 241: 88-98, 2005.
34. La Flamme KE, LaTempa TJ, Grimes CA and Desai TA: The effects of cell density and device arrangement on the behaviour of macroencapsulated beta-cells. Cell Transplant 16: 765-774, 2007.
35. Halban PA, Wollheim CB, Blondel B, Meda P, Niesor EN and Mintz DH: The possible importance of contact between pancreatic islet cells for the control of insulin release. Endocrinology 111: 86-94, 1982.
36. Sandler S, Andersson A, Eizirik DL, Hellerström C, Espevik T, Kulseng B, Thu B, Pipeleers DG and Skjåk-Braek G: Assessment of insulin secretion in vitro from microencapsulated fetal porcine islet-like cell clusters and rat, mouse, and human pancreatic islets. Transplantation 63: 1712-1718, 1997.
37. Lopez-Avalos MD, Tatarkiewicz K, Sharma A, Bonner-Weir S and Weir GC: Enhanced- maturation of porcine neonatal pancreatic cell clusters with growth factors fails to improve transplantation outcome. Transplantation 71: 1154-1162, 2001.